Ascinta is a medical technology company specializing in AI-enabled medical image analysis software and services for radiopharmaceutical therapies. Ascinta supports theranostics clinics, leading research institutions, and pharmaceutical companies with specialized expertise in dosimetry, quantitative nuclear medicine imaging, and protocol optimization to accelerate the development and adoption of novel theranostic solutions. By delivering transformative products and services, Ascinta is dedicated to making personalized radiopharmaceutical therapy a global standard of care, paving the way for a safer, more effective future for cancer treatments.